Attached files
file | filename |
---|---|
10-Q - 10-Q - CHAMPIONS ONCOLOGY, INC. | c93448e10vq.htm |
EX-32.1 - EXHIBIT 32.1 - CHAMPIONS ONCOLOGY, INC. | c93448exv32w1.htm |
EX-31.1 - EXHIBIT 31.1 - CHAMPIONS ONCOLOGY, INC. | c93448exv31w1.htm |
EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
Section 302 Certification
Section 302 Certification
I, Mark R. Schonau, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q of
Champions Biotechnology, Inc., a Delaware corporation; |
|
2. | Based on my knowledge, this report does not contain any
untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light
of the circumstances under which such statements were made,
not misleading with respect to the period covered by this
report; |
|
3. | Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present
in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for,
the periods presented in this report; |
|
4. | The registrants other certifying officer(s) and I are
responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and
15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and
procedures, or caused such disclosure
controls and procedures to be designed under
our supervision, to ensure that material
information relating to the registrant,
including its consolidated subsidiaries, is
made known to us by others within those
entities, particularly during the period in
which this report is being prepared; |
||
(b) | Designed such internal control over financial
reporting, or caused such internal control
over financial reporting to be designed under
our supervision, to provide reasonable
assurance regarding the reliability of
financial reporting and the preparation of
financial statements for external purposes in
accordance with generally accepted accounting
principles; |
||
(c) | Evaluated the effectiveness of the
registrants disclosure controls and
procedures and presented in this report our
conclusions about the effectiveness of the
disclosure controls and procedures, as of the
end of the period covered by this report
based on such evaluation; and |
||
(d) | Disclosed in this report any change in the
registrants internal control over financial
reporting that occurred during the
Registrants most recent fiscal quarter (the
Registrants fourth fiscal quarter in the
case of an annual report) that has materially
affected, or is reasonably likely to
materially affect, the Registrants internal
control over financial reporting; and |
5. | The registrants other certifying officer(s) and I have
disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrants
auditors and the audit committee of the registrants board of
directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material
weaknesses in the design or operation of
internal control over financial reporting
which are reasonably likely to adversely
affect the registrants ability to record,
process, summarize and report financial
information; and |
||
(b) | Any fraud, whether or not material, that
involves management or other employees who
have a significant role in the registrants
internal control over financial reporting. |
Date: December 15, 2009 | /s/ Mark R. Schonau | |||
Mark R. Schonau | ||||
Chief Financial Officer |